ESC 365 - Case 2: discontinuation of cardiac medications after cancer treatment-related cardiac dysfunction

Delegates Premium Access

Case 2: discontinuation of cardiac medications after cancer treatment-related cardiac dysfunction

Session: Clinical Case Management: evolving paradigms in cardio-oncology

Topic: Cardiovascular Toxicity of Cancer Therapies

Speaker: Doctor G. Gulati (Oslo, NO)

Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

About the speaker

Doctor Geeta Gulati

Oslo University Hospital Ulleval, Oslo (Norway)

4 presentations

1 follower

4 more presentations in this session

Case 1: permissive cardiotoxicity

Speaker: Doctor D. Leong (Hamilton, CA)

Case 3: bi-directional cardio-oncology

Speaker: Professor R. De Boer (Rotterdam, NL)

Case 4: risk guided cardioprotection in cardio-oncology

Speaker: Doctor A. Thomas (Durham, US)

Clinical Case Management: evolving paradigms in cardio-oncology - discussion

Access the full session

Clinical Case Management: evolving paradigms in cardio-oncology

Speakers: Doctor G. Gulati, Doctor D. Leong, Professor R. De Boer, Doctor A. Thomas

About the event

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources